The management of female voiding dysfunction: Fowler's syndrome - A contemporary update

Current Opinion in Urology

Volumn 13, Issue 4, 2003, Pages 293-299

  DasGupta, Ranan ^a   Fowler, Clare J ^a  

^a NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

Author keywords

Fowler's syndrome; Sacral neuromodulation; Women in retention

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BETHANECHOL; BOTULINUM TOXIN; CHOLINERGIC RECEPTOR STIMULATING AGENT;

BLADDER CONTRACTION; BLADDER NECK STENOSIS; CLINICAL FEATURE; CYSTOMETRY; ELECTROSTIMULATION; FEMALE; FOWLER SYNDROME; HUMAN; MICTURITION DISORDER; NERVE; NERVE STIMULATION; NEUROMODULATION; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; REVIEW; SACRAL PLEXUS; URETHRA; URINE RETENTION;

ADRENERGIC ALPHA-AGONISTS; BOTULINUM TOXIN TYPE A; ELECTRIC STIMULATION THERAPY; FEMALE; HUMANS; LUMBOSACRAL PLEXUS; SYNDROME; URETHRA; URINARY BLADDER NECK OBSTRUCTION; URINARY RETENTION;

EID: 0041866634     PISSN: 09630643     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042307-200307000-00005     Document Type: Review

References (50)

1. Fowler CJ, Christmas TJ, Chapple CR, et al. Abnormal electromyographic activity of the urethral sphincter, voiding dysfunction, and polycystic ovaries: a new syndrome? BMJ 1988; 297:1436-1438.
2. Hassouna MM, Siegel SW, Nyeholt AA, et al. Sacral neuromodulation in the treatment of urgency-frequency symptoms: a multicenter study on efficacy and safety. J Urol 2000; 163:1849-1854.
3. Janknegt RA, Hassouna MM, Siegel SW, et al. Long-term effectiveness of sacral nerve stimulation for refractory urge incontinence. Eur Urol 2001; 39:101-106.
4. Abrams PH, Griffiths DJ. The assessment of prostatic obstruction from urodynamic measurements and from residual urine. BJU 1979; 51:129-134.
5. Schafer W. Basic principles and clinical application of advanced analysis of bladder voiding function. Urol Clin North Am 1990; 17:553-566.
6. Griffiths D, Hofner K, van Mastrigt R, et al. Standardization of terminology of lower urinary tract function: pressure-flow studies of voiding, urethral resistance, and urethral obstruction. International Continence Society Subcommittee on Standardization of Terminology of Pressure-Flow Studies. Neurourol Urodyn 1997; 16:1-18.
7. Massey JA, Abrams PH. Obstructed voiding in the female. Br J Urol 1988; 61:36-39.
8. Farrar DJ, Osborne JL, Stephenson TP, et al. A urodynamic view of bladder outflow obstruction in the female: factors influencing the results of treatment. Br J Urol 1975; 47:815-822.
9. Chassagne S, Bernier PA, Haab F, et al. Proposed cutoff values to define bladder outlet obstruction in women. Urology 1998; 51:408-411.
10. Lemack GE, Zimmern PE. Pressure flow analysis may aid in identifying women with outflow obstruction. J Urol 2000; 163:1823-1828.
11. Blaivas JG, Groutz A. Bladder outlet obstruction nomogram for women with lower urinary tract symptomatology. Neurourol Urodyn 2000; 19:553-564.
12. Cormier L, Ferchaud J, Galas JM, et al. Diagnosis of female bladder outlet obstruction and relevance of the parameter area under the curve of detrusor pressure during voiding: preliminary results. J Urol 2002; 167:2083-2087. This paper advances beyond simple urodynamic criteria for bladder outflow obstruction by incorporating effort required in order to void, based on the area under the curve in a pressure-flow study, with normative values proposed for women who are obstructed, equivocal and unobstructed.
13. Kranse R, van Mastrigt R. Relative bladder outlet obstruction. J Urol 2002; 168:565-570. A novel approach to classifying female bladder outlet obstruction by combining quantified detrusor contractility and outlet resistance in the assessment of female outflow obstruction.
14. Lemack GE, Foster B, Zimmern PE. Urethral dilation in women: a questionnaire-based analysis of practice patterns. Urology 1999; 54:37-43.
15. Rutherford A, Hinshaw K, Essenhigh D, Neal D. Urethral dilatation compared with cystoscopy alone in the treatment of women with recurrent frequency and dysuria. BJU 1988; 61:500-504.
16. Fowler CJ, Kirby RS. Electromyography of urethral sphincter in women with urinary retention. Lancet 1986; 1:1455-1457.
17. Deindl F, Vodusek D, Bischoff C, et al. Dysfunctional voiding in women: which muscles are responsible? BJU 1998; 82:814-819.
18. Wiseman OJ, Swinn MJ, Brady CM, Fowler CJ. Maximum urethral closure pressure and sphincter volume in women with urinary retention. J Urol 2002; 167:1348-1351; discussion 1351-1352. A study showing two ancillary investigations that may be helpful in identifying women in retention who are likely to have an abnormal electromyography.
19. Swinn MJ, Wiseman OJ, Lowe E, Fowler CJ. The cause and natural history of isolated urinary retention in young women. J Urol 2002; 167:151-156. A review of a large series of women with Fowler's syndrome, with descriptive details of the condition and mode of presentation.
20. Williams A, Taylor K, Bates C, et al. Knowledge of female bladder care among medical staff, nurses and midwives: results of a questionnaire survey. BJUI 2003; 91:208-210. A postal questionnaire survey of junior medical staff and nursing staff that highlights the need to provide adequate basic training in bladder management, particularly after surgery.
21. Lose G, Griffiths D, Hosker G, et al. Standardisation of urethral pressure measurement: report from the Standardisation Sub-Committee of the International Continence Society. Neurourol Urodyn 2002; 21:258-260. A consensus opinion on how to report urethral pressure profiles and the techniques involved.
22. Noble JG, Dixon PJ, Rickards D, Fowler CJ. Urethral sphincter volumes in women with obstructed voiding and abnormal sphincter electromyographic activity. Br J Urol 1995; 76:741-746.
23. Spinelli M, Bertapelle P, Cappellano F, et al. Chronic sacral neuromodulation in patients with lower urinary tract symptoms: results from a national register. J Urol 2001; 166:541-545.
24. Kumar A, Mandhani A, Gogoi S, Srivastava A. Management of functional bladder neck obstruction in women: use of alpha-blockers and pediatric resectoscope for bladder neck incision. J Urol 1999; 162:2061-2065.
25. Riedl CR, Stephen RL, Daha LK, et al. Electromotive administration of intravesical bethanechol and the clinical impact on acontractile detrusor management: introduction of a new test. J Urol 2000; 164:2108-2111.
26. Phelan M, Franks M, Somogyi G, et al. Botulinum toxin urethral sphincter injection to restore bladder emptying in men and women with voiding dysfunction. J Urol 2001; 165:1107-1110.
27. Fowler CJ, Betts CD, Christmas TJ, et al. Botulinum toxin in the treatment of chronic urinary retention in women. Br J Urol 1992; 70:387-389.
28. Tanagho E, Schmidt R. Electrical stimulation in the clinical management of the neurogenic bladder. J Urol 1988; 140:1331-1339.
29. Bosch R, Green J. Sacral neuromodulation in the treatment of patients with refractory motor urge incontinence: long-term results of a prospective longitudinal study. J Urol 2000; 163:1219-1222.
30. Janknegt R, Weil E, Eerdmans P. Improving neuromodulation: technique for refractory voiding dysfunctions: two-stage implant. Urology 1997; 49:358-362.
31. Edlund C, Hellstrom P, Fall M. First Scandinavian experience of electrical sacral nerve stimulation in the treatment of the overactive bladder. Scand J Urol Nephrol 2000; 34:366-376.
32. Swinn MJ, Schott GD, Oliver SE, et al. Leg pain after sacral neuromodulation: anatomical considerations. BJU Int 1999; 84:1113-1115.
33. Hohenfellner M, Schultz-Lampel D, Dahms S, et al. Bilateral chronic sacral neuromodulation for treatment of lower urinary tract dysfunction. J Urol 1998; 160 (3 Pt 1):821-824.
34. Scheepens WA, de Bie RA, Weil EH, van Kerrebroeck PE. Unilateral versus bilateral sacral neuromodulation in patients with chronic voiding dysfunction. J Urol 2002; 168:2046-2050. Paper that shows limited advantage with bilateral implantation, with some benefit in cases of retention.
35. Carey M, Fynes M, Murray C, Maher C. Sacral nerve root stimulation for lower urinary tract dysfunction: overcoming the problem of lead migration. BJU Int 2001; 87:15-18.
36. Chai TC, Mamo GJ. Modified techniques of S3 foramen localization and lead implantation in S3 neuromodulation. Urology 2001; 58:785-790.
37. Spinelli M, Giardiello G, Arduini A, van den Hombergh U. New percutaneous technique of sacral nerve stimulation has high initial success rate: preliminary results. Eur Urol 2003; 43:70-74. Exciting new percutaneous approach to implantation, which may become increasingly popular.
38. Jonas U, Fowler CJ, Chancellor MB, et al. Efficacy of sacral nerve stimulation for urinary retention: results 18 months after implantation. J Urol 2001; 165:15-19.
39. Swinn MJ, Kitchen ND, Goodwin RJ, Fowler CJ. Sacral neuromodulation for women with Fowler's syndrome. Eur Urol 2000; 38:439-443.
40. Shaker HS, Hassouna M. Sacral root neuromodulation in idiopathic nonobstructive chronic urinary retention. J Urol 1998; 159:1476-1478.
41. Abosief S, Tamaddon K, Chalfin S, et al. Sacral neuromodulation in functional urinary retention: an effective way to restore voiding. BJUI 2002; 90:662-665. Short review of diary-based results following implantation.
42. Wiseman OJ, van den Hombergh U, Koldewijn EL, et al. Sacral neuromodulation and pregnancy. J Urol 2002; 167:165-168. Paper reviewing six cases of pregnant women with implants.
43. Fowler CJ, Swinn MJ, Goodwin RJ, et al. Studies of the latency of pelvic floor contraction during peripheral nerve evaluation show that the muscle response is reflexly mediated. J Urol 2000; 163:881-883.
44. Wyndaele J, Michielsen D, Van Dromme S. Influence of sacral neuromodulation on electrosensation of the lower urinary tract. J Urol 2000; 163:221-224.
45. Wang Y, Hassouna MM. Neuromodulation reduces c-fos gene expression in spinalized rats: a double-blind randomized study. J Urol 2000; 163:1966-1970.
46. Zhou Y, Wang Y, Abdelhady M, et al. Change of vanilloid receptor 1 following neuromodulation in rats with spinal cord injury. J Surg Res 2002; 107:140-144. Work by this group has pointed to the importance of neurctransmitters in our understanding of neuromodulation.
47. DasGupta R, Apostolidis A, Fowler C. Urodynamic results following successful sacral neuromodulation in women with urinary retention [abstract]. Eur Urol 2003; 2 (Suppl):70.
48. Braun PM, Baezner H, Self C, et al. Alterations of cortical electrical activity in patients with sacral neuromodulator. Eur Urol 2002; 41:562-566; discussion 566-567.
49. Blok BF, Willemsen ATM, Holstege G. A PET study on brain control of micturition in humans. Brain 1997; 120:111-121.
50. Blok BF, Sturms LM, Holstege G. Brain activation during micturition in women. Brain 1998; 121 (Pt 11):2033-2042.